Skip to content

Faculty profile

Richard Schulz

Back to faculty
ResearcherPediatrics/PharmacologyUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.

Latest papers

  • MMP-2 inhibition attenuates ER stress-mediated cell death during myocardial ischemia-reperfusion injury by preserving IRE1α.

    Journal of molecular and cellular cardiology · 2025 · senior author

  • Matrix metalloproteinase inhibition protects against junctophilin-2 proteolysis during doxorubicin-induced cardiotoxicity.

    British journal of pharmacology · 2025 · senior author

  • Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metalloproteinase-2 contributes to vascular dysfunction in early hypertension.

    European journal of pharmacology · 2024

All 80 publications

Latest funding

  • Matrix metalloproteinases in cardiovascular health and disease: from bench to bedside

    CIHR · 2014 · Nominated PI

    $1,794,502
  • Role of matrix metalloproteinase (MMP)-2 in regulating smooth muscle contraction

    NSERC · 2011 · Principal investigator

    $200,000
  • Novel regulation and targets of matrix metalloproteinase-2 in the ischemic heart

    CIHR · 2010 · Nominated PI

    $655,391
All 4 grants and awards
Something wrong or missing on this profile? Suggest a correction